4D Share Price

4D Share Price

NASDAQ: FDMT | Small Cap | Healthcare
$10.44
-$0.34 (-3.15%) Last updated on 19 Nov, 2026 | 01:27 IST
  • Performance
  • Chart
  • Fundamentals
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • About
  • Price history
  • FAQs

4D Stock Performance

Open
$10.70
Prev. Close
$10.78
Circuit Range
N/A
Day Range
$10.31 - $10.97
Year Range
$6.96 - $16.91
Volume
23,930
Average Traded
$10.53

4D Share Price Today

As of 19 November 2026, 4D Molecular Therapeutics, Inc.'s share price is $10.44. The stock opened at $10.70, compared to its previous close of $10.78. During today's trading session, 4D Molecular Therapeutics, Inc.'s share price traded between $10.31 and $10.97, with an average price of $10.64. Over the past 52 weeks, the stock has recorded a high of $16.91 and a low of $6.96. In terms of performance, 4D Molecular Therapeutics, Inc.'s share price has risen by 5.03% over the last six months and is down 10.69% on a year-on-year basis.

4D Share Price Chart

Line chart of the 4D price trend over the selected period. The price fell overall, ranging from 10.32 to 11.00, ending at 10.44.
$10.31$10.97
L
Show Current Price
H

4D Stock Fundamentals & Key Indicators

Market Cap
$604.79M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-3.18
Revenue (TTM)
$85.21B
Return On Equity (TTM)
-43.95%
Profit Margin
-164.43%
Debt to Equity
0.05
Quarterly Earnings Growth YoY
-28.23%

4D Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$0.09$85.09$3.05$3.78
Net Profit-$56.88$19.40-$68.76-$72.94
Net Profit Margin-63200.00%22.80%-2254.43%-1929.63%
Income ChangeN/A134.11%-454.43%-6.08%

4D Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$3.13$20.72$0.04$85.21
Net Profit-$107.49-$100.84-$160.87-$140.11
Net Profit Margin-3434.19%-486.68%-402175.00%-164.43%
Income ChangeN/A6.19%-59.53%12.90%

4D Balance Sheet

All figures in USD Million

Particulars2025202420232022
Non Current Assets153.58125.4543.341.34
Current Assets413.13434.93296.59220.51
Total Assets566.71560.38339.89261.85
Non Current Liabilities17.0620.6313.1114.78
Current Liabilities43.9929.1518.9515.73
Total Liabilities61.0549.7832.0630.51
Shareholders' Equity505.66510.61307.83231.34

4D Cash Flow

Annually

All figures in USD Million

Particulars2025202420232022
Operating-109.08-134.59-75.79-86.69
Investing-92.97-302.44115.72-17.05
Financing112.96337.25156.833.09

About 4D

4D Molecular Therapeutics Inc is biotechnology company advancing durable and disease-targeted therapeutics with potential to transform treatment paradigms and provide unprecedented benefits to patients. Companies focus is on advancing 4D-150 for wet age-related macular degeneration (wet AMD) and diabetic macular edema (DME) through late-stage studies. It has built a portfolio of gene therapy product candidates focused on three therapeutic areas: Ophthalmology (intravitreal vector) includes 4D-150, 4D-710 and 4D-175; Cardiology (intravenous vector) includes 4D-710, 4D-725, and Pulmonology (aerosol vector).

4D Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$11.96
$10.38
-12.59%
Oct 2026
$14.37
$11.88
-17.07%
Sep 2026
$14.04
$14.32
-3.83%
Aug 2026
$10.17
$14.89
+46.27%
Jul 2026
$13.12
$10.18
-23.43%
Jun 2026
$9.97
$13.29
+33.75%
May 2026
$9.01
$9.94
+11.94%
Apr 2026
$9.63
$8.88
-4.41%
Mar 2026
$9.34
$9.29
-3.93%
Feb 2026
$8.85
$9.67
+9.14%
Jan 2026
$7.59
$8.86
+18.45%
Dec 2025
$11.43
$7.48
-36.01%

4D Share Price FAQs